chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARZOS
Symptoms: Brain fog, Fatigue, Headache
Clinical narrative: headache; Brain fog; fatigue; This non-serious case was reported by a physician via sales rep and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, 2 weeks after receiving Shingrix, the patient experienced headache (Verbatim: headache), brain fog (Verbatim: Brain fog) and fatigue (Verbatim: fatigue).  The outcome of the headache, brain fog and fatigue were unknown.   It was unknown if the reporter considered the headache, brain fog and fatigue to be related to Shingrix.     It was unknown if the company considered the headache, brain fog and fatigue to be related to Shingrix.   Additional Information: GSK Receipt Date: 25-SEP-2023 The doctor asked about the possible side effects of shingrix which might occured 2 weeks after receiving shingrix vaccination. The patient stated that she had headache, fatigue and brain fog after 2 weeks of Shingrix administration. This case is linked with US2023AMR135282, same suspect, same reporter and different patient. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023AMR135282:same suspect, same reporter US-GSK-US2023AMR135282:wife case
Sex: U
Vaccine: HEPAB
Symptoms: Expired product administered
Clinical narrative: Twinrix: expired dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received HAB (Twinrix) (batch number 2KE55, expiry date 22-SEP-2023) for prophylaxis.   On 25-SEP-2023, the patient received Twinrix. On 25-SEP-2023, an unknown time after receiving Twinrix, the patient experienced expired vaccine used (Verbatim: Twinrix: expired dose administered).  The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 26-Sept-2023 The case was received from the health care professional. The reporter consented to follow-up. The patient received an expired dose of Twinrix, which led to expired vaccine used.
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received the second dose of Shingrix in June of 2023 and the first dose in July of 2022; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose in July 2022).   In JUN-2023, the patient received the 2nd dose of Shingrix. In JUN-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: patient received the second dose of Shingrix in June of 2023 and the first dose in July of 2022).  The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 26-Sept-2023 Nurse could not provide patient identifiers, lot numbers, or expiration dates.  The reporter could not provide exact date of administration of either dose of Shingrix.  No additional information was provided. The reporter consented to follow-up. The patient received second dose of Shingrix later than the recommended interval, which led to lengthening of vaccine schedule.
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: patient received an expired dose of Boostrix today. Vaccine expired on 24-SEP-2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 12-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis.   On 26-SEP-2023, the patient received Boostrix. On 26-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: patient received an expired dose of Boostrix today. Vaccine expired on 24-SEP-2023).  The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 26-Sept-2023 The case was received from the registered nurse. The reporter consented to follow-up. The patient received an expired dose of Boostrix, which led to expired vaccine used.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Influenza like illness
Clinical narrative: flu like symptoms; This non-serious case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 66-year-old male patient who received Herpes zoster (Shingrix) (batch number 5777F) for prophylaxis.   On 25-SEP-2023, the patient received the 1st dose of Shingrix (intramuscular). On 25-SEP-2023, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: flu like symptoms).  The outcome of the influenza-like symptoms was not resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.     It was unknown if the company considered the influenza-like symptoms to be related to Shingrix.   Additional Information: GSK Receipt Date: 26-SEP-2023 The patient reported when he administered the first dose of Shingrix on 25 September 2023 and went home he had the flu like symptoms. He stated the flu like symptoms was still ongoing at the time of reporting. The patient did not elaborate on the flu-like symptoms. The patient was driving and was not able to answer many questions. He offered after call survey.
Sex: M
Vaccine: RSV
Symptoms: Dyspnoea, Headache, Influenza like illness, Pain in extremity
Clinical narrative: painful fingers/painful arm; inability to take deep breaths; flu-like symptoms; headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in fingers in a 73-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 14-SEP-2023, the patient received Arexvy. On 14-SEP-2023, less than a day after receiving Arexvy, the patient experienced pain in fingers (Verbatim: painful fingers/painful arm), difficulty breathing (Verbatim: inability to take deep breaths), influenza-like symptoms (Verbatim: flu-like symptoms) and headache (Verbatim: headache).  On 18-SEP-2023, the outcome of the pain in fingers, difficulty breathing, influenza-like symptoms and headache were resolved (duration 4 days).   It was unknown if the reporter considered the pain in fingers, difficulty breathing, influenza-like symptoms and headache to be related to Arexvy.     It was unknown if the company considered the pain in fingers, difficulty breathing, influenza-like symptoms and headache to be related to Arexvy.   Additional Information: GSK receipt date: 26-Sept-2023 The patient who received Arexvy vaccine and experienced the following symptoms: painful arm, inability to take deep breaths, flu-like symptoms, headache and painful fingers.  The patient stated that the symptoms all appeared later the same day as the vaccination and they were all gone in 4 days. No consent to contact physician, the patient did not want to involve him. Did not consent to follow-up.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient received the first dose of SHINGRIX on September 8, 2023, and the second dose of SHINGRIX  on September 23, 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 2R375, expiry date 28-MAY-2024) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 23-SEP-2023, the patient received the 2nd dose of Shingrix. On 23-SEP-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: patient received the first dose of SHINGRIX on September 8, 2023, and the second dose of SHINGRIX  on September 23, 2023).  The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 26-Sept-2023 The case was received from the pharmacist. The reporter did not consent to follow-up. The patient received second dose of Shingrix earlier than the recommended interval, which led to shortening of vaccine schedule.
Age: 25.0
Sex: F
Vaccine: TD
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered
Clinical narrative: Reviewed patient's internal immunization screen as well as system. Last Tdap vaccine was listed as 11/14/11. Discussed need for TD vaccine, asked patient if she had received a tetanus vaccine since this time. Patient reports she had not. Pulled TD vaccine, verified need with second RN by reviewing internal immunization screen as well as system. Issued vaccine and administered in EHR. After charting on patient, I noticed a TD vaccine listed from 7/15/2021 on the lower right portion of patient's home screen in EHR. Vaccine was given on 7/15/2021 but was not coded on the encounter for billing; therefore, causing it to not make it on to the internal immunization screen or system. After notifying supervisor, I inputted the TD and Pneumovax 23 in to system that was administered on 7/15/2021 to avoid future duplication of vaccines.
Sex: M
Vaccine: MNQ
Symptoms: Incorrect dose administered, Product preparation error, Single component of a two-component product administered
Clinical narrative: patient was inadvertently administered the Liquid Diluent component of Menveo without the Lyophilized component on 9/22/2023.; patient was inadvertently administered the Liquid Diluent component of Menveo without the Lyophilized component on 9/22/2023.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA732A, expiry date 31-OCT-2023) for prophylaxis.   On 22-SEP-2023, the patient received Menveo. On 22-SEP-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: patient was inadvertently administered the Liquid Diluent component of Menveo without the Lyophilized component on 9/22/2023.) and inappropriate dose of vaccine administered (Verbatim: patient was inadvertently administered the Liquid Diluent component of Menveo without the Lyophilized component on 9/22/2023.).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 26-Sept-2023 Pharmacist called to inquired that how to proceed and they should revaccinate. The reporter was unable to provide patient details. Did not consent to follow-up. The patient was inadvertently administered the liquid diluent component of Menveo without the lyophilized component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Age: 12.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: patient received a dose of Boostrix that expired the day before she was administered it; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 12-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2ZF9N, expiry date 24-SEP-2023) for prophylaxis.   On 25-SEP-2023, the patient received Boostrix. On 25-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: patient received a dose of Boostrix that expired the day before she was administered it).  The outcome of the expired vaccine used was unknown.   Additional Information: GSK receipt date: 26-Sept-2023 The case was received from the registered nurse. The reporter consented to follow-up. The patient received an expired dose of Boostrix, which led to expired vaccine used.
Age: 80.0
Sex: F
Vaccine: RSV
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: leaking of the vaccine, and an incomplete dose administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 80-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 35AD3) for prophylaxis.   On 26-SEP-2023, the patient received Arexvy. On 26-SEP-2023, an unknown time after receiving Arexvy, the patient experienced incomplete dose administered (Verbatim: leaking of the vaccine, and an incomplete dose administered).The outcome of the incomplete dose administered was unknown.   Additional Information: GSK Receipt Date: 26-SEP-2023 The reporter called to inform that earlier that day, a patient moved their arm during the administration of a dose of Arexvy and this resulted in the leaking of the vaccine and an incomplete dose administered, which led to incomplete dose administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.
Sex: M
Vaccine: UNK
Symptoms: Extra dose administered
Clinical narrative: patient was inadvertently given 2 doses Flulaval; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 65-year-old male patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2023-2024 season) for prophylaxis.   Previously administered products included FluLaval Quadrivalent (received on an unknown date).   On 15-SEP-2023, the patient received FluLaval Quadrivalent 2023-2024 season. On 15-SEP-2023, an unknown time after receiving FluLaval Quadrivalent 2023-2024 season, the patient experienced extra dose administered (Verbatim: patient was inadvertently given 2 doses Flulaval).  The outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 27-SEP-2023 The patient was inadvertently given 2 doses Flulaval, which led to extra dose administered. No symptoms reported. The HCP did not have date of birth or lot/expiry at time of report. Healthcare professional (HCP) consented to follow-up via email.
Sex: F
Vaccine: HEPAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate Schedule of Vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received HAB (Twinrix adult) for prophylaxis.   Previously administered products included Twinrix adult (received 1st dose in OCT-2022).   In SEP-2023, the patient received the 2nd dose of Twinrix adult. In SEP-2023, an unknown time after receiving Twinrix adult, the patient experienced drug dose administration interval too long (Verbatim: Inappropriate Schedule of Vaccine).  The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 27-SEP-2023 Pharmacist requested guidance on Twinrix series. Exact dates of vaccines unknown as patient received at a different pharmacy. Pharmacist disconnected call prior to confirming Safety team follow-up. The patient received the 2nd dose later than recommended interval, which led to lengthening of vaccination schedule.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Accidental exposure to product, Exposure via skin contact, Incorrect dose administered, Needle issue
Clinical narrative: during administration of Shingrix half of the dose leaked out of the needle; during administration of Shingrix half of the dose leaked out of the needle and down the patients arm; during administration of Shingrix half of the dose leaked out of the needle and down the patients arm; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number 2Z9N3, expiry date 26-SEP-2025) for prophylaxis.   On 27-SEP-2023, the patient received Shingrix. On 27-SEP-2023, an unknown time after receiving Shingrix, the patient experienced accidental underdose (Verbatim: during administration of Shingrix half of the dose leaked out of the needle), exposure via skin contact (Verbatim: during administration of Shingrix half of the dose leaked out of the needle and down the patients arm) and inadvertent exposure to vaccine (Verbatim: during administration of Shingrix half of the dose leaked out of the needle and down the patients arm).  The outcome of the accidental underdose, exposure via skin contact and inadvertent exposure to vaccine were unknown.   Additional Information: GSK Receipt Date: 28-SEP-2023 Pharmacist reports during administration of Shingrix half of the dose leaked out of the needle and down the patients arm, which led to accidental underdose, exposure via skin contact and inadvertent exposure to vaccine. The reporter consented to follow up.
Age: 76.0
Sex: M
Vaccine: FLUA4, RSV
Symptoms: Constipation, Dizziness, Dizziness exertional, Dizziness postural, Pain
Clinical narrative: dizziness/he feels like he is going to pass out; soreness; constipation; fells dizzy when standing up/dizziness is worse when he is laying down; fells dizzy when walking; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in a 76-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE INACT SAG 3V (FLUAD 65+ INFLUENZA VACCINE) for prophylaxis and meclozine (Meclizine) for dizziness.   Concurrent medical conditions included solitary kidney.   On 25-SEP-2023, the patient received Arexvy (unknown arm) and FLUAD 65+ INFLUENZA VACCINE (unknown arm). In SEP-2023, the patient started Meclizine 25 mg. In SEP-2023, an unknown time after receiving Arexvy, the patient experienced constipation (Verbatim: constipation), dizziness upon standing (Verbatim: fells dizzy when standing up/dizziness is worse when he is laying down) and dizziness exertional (Verbatim: fells dizzy when walking). On 25-SEP-2023, the patient experienced pain (Verbatim: soreness). On 26-SEP-2023, the patient experienced dizziness (Verbatim: dizziness/he feels like he is going to pass out).  The patient was treated with paracetamol (Tylenol). The action taken with Meclizine was unknown. The outcome of the pain, dizziness upon standing and dizziness exertional were resolving and the outcome of the dizziness was not resolved and the outcome of the constipation was unknown.   It was unknown if the reporter considered the pain, dizziness, constipation, dizziness upon standing and dizziness exertional to be related to Arexvy.     It was unknown if the company considered the pain, dizziness, constipation, dizziness upon standing and dizziness exertional to be related to Arexvy.   Additional Information: GSK Receipt date: 28-SEP-2023 The patient was self-reported.  The patient received AREXVY on Monday, also received FLUAD- 65 plus at the same time.  The vaccines were administered in opposite arms and the patient experienced soreness the day of the vaccinations, in which he took Tylenol to alleviate the soreness.  The day after receiving the vaccines (Tuesday), the patient began to experience dizziness.  The patient fells dizzy when standing up and walking, however, the patient described the dizziness was worse when he was laying down as he feels like he was going to pass out.  The patient stated he feels better during the afternoons, but stated the dizziness starts back up the next day. The patient was taking Meclizine 25 mg for the dizziness.  The patient was also experiencing constipation. The patient stated that the constipation might be related to the Meclizine.  It was unknown if the reporter considered the pain, dizziness, constipation, dizziness upon standing and dizziness exertional to be related to FLUAD- 65 plus.    The reporter consented to follow up.
Sex: M
Vaccine: RSV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: redness at the injection site; redness and tenderness at the injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 75BS5) for prophylaxis.   On 22-SEP-2023, the patient received Arexvy. In SEP-2023, an unknown time after receiving Arexvy, the patient experienced injection site erythema (Verbatim: redness at the injection site) and injection site tenderness (Verbatim: redness and tenderness at the injection site).  The outcome of the injection site erythema and injection site tenderness were resolved.   The reporter considered the injection site erythema and injection site tenderness to be related to Arexvy.     The company considered the injection site erythema and injection site tenderness to be related to Arexvy.   Additional Information: GSK receipt date 28 Sep 2023 The reporter was the wife of the patient. She reported that her husband received a shot of AREXVY  last Friday. He experienced redness and tenderness at the injection site. These issue was resolved. The reporter provided limited information.  The reporter did not consent to follow-up.; Sender's Comments:  US-GSK-US2023133798:Same reporter, different patient
Sex: F
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: received first dose of Shingrix 2 years ago and hasn't receive a second dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included SHINGRIX (received 1st dose on unknown date 2 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received first dose of Shingrix 2 years ago and hasn't receive a second dose yet).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date 28 Sep 2023 The pharmacist called to report patient received first dose of Shingrix 2 years ago and had not received a second dose yet. No specific vaccination date or vaccine details reported; only that it was two years ago. The reporter consented to follow up via email. Till the time of reporting the patient did not receive 2nd dose which led to incomplete course of vaccination.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received a dose of Shingrix on 26Sep2023 that was exposed to a temperature excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 3J972, expiry date 20-AUG-2024) for prophylaxis.   On 26-SEP-2023, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: received a dose of Shingrix on 26Sep2023 that was exposed to a temperature excursion).  The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 28-Sept-2023 No symptoms were reported. The reporter consented to follow-up via email. This is 1 of 3 linked cases reported by the same reporter. The patient received a dose of Shingrix after temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023133819:same reporter different patient. US-GSK-US2023133821:samereporter, different pateint,different drug.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: C-reactive protein, Full blood count, Injection site discolouration, Injection site erythema, Injection site mass
Clinical narrative: Patient states there was a "knot" near the vaccination site for about 10 days. Became a dime size red bump, then a increasing black spot near site-painful. There was also rash-like area around site. When seen in office on 9/25- necrotic spot at site. Very painful, no drainage.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site necrosis, Injection site pain, Injection site rash, Metabolic function test, Red blood cell sedimentation rate
Clinical narrative: Patient states there was a "knot" near the vaccination site for about 10 days. Became a dime size red bump, then a increasing black spot near site-painful. There was also rash-like area around site. When seen in office on 9/25- necrotic spot at site. Very painful, no drainage.
Age: 41.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Joint stiffness, Mobility decreased
Clinical narrative: Right Knee sore and stiffness, restricting motion
Age: 76.0
Sex: M
Vaccine: RSV
Symptoms: Arthralgia, Back pain, Sciatica
Clinical narrative: Patient called stating that on 09/08/2023 he received a flu shot and the RSV shot (Arexvy) and over the next couple days, he developed very painful "sciatica" pain in his low back and hip.  He had never experienced this type of pain before.  He stated it lasted approximately 3 weeks and then resolved. He did not seek medical care, just managed at home.  Since he had never had the RSV vaccine before, and could not recall any other changes at the time, he thought it could have been an adverse reaction to the RSV shot and wanted to report to the pharmacy.
Age: 31.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Swelling and redness at insertion site along with intermittent itching
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: received a dose of Shingrix on 26Sep2023 that was exposed to a temperature excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 56-year-old male patient who received Herpes zoster (Shingrix) (batch number 3J972, expiry date 20-AUG-2024) for prophylaxis.   On 26-SEP-2023, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: received a dose of Shingrix on 26Sep2023 that was exposed to a temperature excursion).  The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 28-Sept-2023 No symptoms were reported. The reporter consented to follow-up via email. This is 2 of 3 linked cases reported by the same reporter. The patient received a dose of Shingrix after temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023133818:same reporter different patient US-GSK-US2023133821:same reporter different patient
Sex: U
Vaccine: COVID19-2, FLUX
Symptoms: Chills, Injection site reaction, Injection site swelling, Musculoskeletal stiffness, Pyrexia
Clinical narrative: swelling and redness around the injection site around 6 cm by 2 cm. Fever & chills 10/4 PM.  right side neck stiffness 10/5
Age: 4.0
Sex: M
Vaccine: DTAP, FLU4, HEP, IPV
Symptoms: Extra dose administered
Clinical narrative: Patient received Hep B that was not needed.  Patient waited 15 min, no s/s of distress noted. Will follow up with patient in a few days.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis, Ultrasound scan
Clinical narrative: Blood clot in right calf, not main vein
Age: 2.0
Sex: F
Vaccine: PNC15
Symptoms: Extra dose administered
Clinical narrative: Mother brought patient into clinic with immunization record. Nurse input vaccine record into database. Database reported patient needed HepA, Pneumococcal, Varicella, and Flu. Nurse reviewed immunization record and database, saw that patient had only had 3 pnemococcal vaccines. Nurse recognized that most children receive 4 pneumococcal vaccines in childhood, did not realize 3rd dose was given >1 year which would complete patient's series. Mother consented to all vaccines and vaccines were administered.
Age: 78.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity
Clinical narrative: Pt states hand hurts 3 days after administration, just reported today 10/5/23, patient states taking an OTC pain reliever for the pain, she is not sure if immunization was given near a nerve
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Blepharospasm, Muscle twitching, Sensory disturbance
Clinical narrative: On 10/02/03, I received the flu vaccine around 1:30 pm. About 1.5 hours later, my right index finger started twitching around 3 pm (I have video). About 5 pm, I had weird sensations in both feet which lasted all night. While sleeping, I woke up around 4 am because my eyelids were rapidly twitching and I also had a nerve twitch in my left calf and right arm. I called my physician on 10/03 and when he called back, I explained what happened. He thinks the nurse hit a nerve and told me I could take Benadryl and if the symptoms got worse or started shooting down my legs to go to the ER. On 10/04, my symptoms had subsided except for occasional foot sensations. I spoke to Occupational Health and reported what happened to them.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Pain in extremity
Clinical narrative: Patient reported arm still sore over 1 month after the immunization, hurts to raise straight up
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: tinnitus
Age: 1.17
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Aphasia, Autism spectrum disorder, Blood aluminium increased, Blood test abnormal, Crying
Clinical narrative: He got his vaccine.  He instantly after the MMR he was talking and he literally went mute and he has not talked since. His eye was turning to the side, became a dead eye, started twitching and jerking, always crying like he was in pain, always banging his ears, and they could not tell her what the problem was.  He became very sensitive to foods, would not eat certain foods, doing sudden movements.  A few months later he started spinning, standing in the floor and spinning.  His head and hands were jerking immediately after that vaccine.  The doctor sent mother for further testing, and informed her that nothing was wrong with his eye and that he was having temporary things.  That doctor left that office, and was then and now seeing a different pediatricians.  He started having high fever, and rashes and was told that he was fine.  He had 3 sets of 5 different shots 9/11/19 at 2 months, the Rotovirus, polio, Hep B, Hip, PCV and Dtab.  Then 11/12/19 he had the same vaccines, then on 1/14/20 he had the same 5 vaccines again.  They did not tell her at that time that they were multiple shots at one until she requested a copy of his records.  She would not have allowed it as it was too many at that time.  Each time after those reactions he was reacting different ways, but the worst one was the MMR.    He was diagnosed with autism at 21 months after testing from reaction to the MMR vaccine.  He was evaluated by the developmental pediatrician and had testing that showed that he had very high levels of aluminum in his system.  He was developing normally, talking, pointing, interacting, social, no eye problems, no twitching prior to this vaccine.  He is not able to talk at all, and prior he was saying 30 words.  He is still having the abnormal jerking and twitching movements, his eyes are going in and out.  The MRI showed that he had internal damage to his ear canal.  He still has high aluminum levels, and has not had any vaccines since then.  They have been waiting for therapy for him as there are no services available for him, there is a waiting list and noone available to give those services.  His blood work prior to this vaccine was normal, and now a lot of his levels are  high and abnormal.  He also has very very dark circles around his eyes.  He is not gaining weight, he is very very picky and does not tolerate textures of food, he does not feed himself, they have been potty training him every day for years, and he is still not potty trained.  He was eating prior to the vaccine.  He was admitted to the hospital and was supposed to have an MRI but the schedule did not accommodate that.  He was crying in pain for his ears, and the jerking movements is why he was admitted, and the MRI showed that he has chronic inflammation and internal damage to the ear canal.  He had no ear issues prior to that vaccine and would respond before.
Age: 1.17
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Dark circles under eyes, Dyskinesia, Ear canal injury, Ear inflammation, Ear pain
Clinical narrative: He got his vaccine.  He instantly after the MMR he was talking and he literally went mute and he has not talked since. His eye was turning to the side, became a dead eye, started twitching and jerking, always crying like he was in pain, always banging his ears, and they could not tell her what the problem was.  He became very sensitive to foods, would not eat certain foods, doing sudden movements.  A few months later he started spinning, standing in the floor and spinning.  His head and hands were jerking immediately after that vaccine.  The doctor sent mother for further testing, and informed her that nothing was wrong with his eye and that he was having temporary things.  That doctor left that office, and was then and now seeing a different pediatricians.  He started having high fever, and rashes and was told that he was fine.  He had 3 sets of 5 different shots 9/11/19 at 2 months, the Rotovirus, polio, Hep B, Hip, PCV and Dtab.  Then 11/12/19 he had the same vaccines, then on 1/14/20 he had the same 5 vaccines again.  They did not tell her at that time that they were multiple shots at one until she requested a copy of his records.  She would not have allowed it as it was too many at that time.  Each time after those reactions he was reacting different ways, but the worst one was the MMR.    He was diagnosed with autism at 21 months after testing from reaction to the MMR vaccine.  He was evaluated by the developmental pediatrician and had testing that showed that he had very high levels of aluminum in his system.  He was developing normally, talking, pointing, interacting, social, no eye problems, no twitching prior to this vaccine.  He is not able to talk at all, and prior he was saying 30 words.  He is still having the abnormal jerking and twitching movements, his eyes are going in and out.  The MRI showed that he had internal damage to his ear canal.  He still has high aluminum levels, and has not had any vaccines since then.  They have been waiting for therapy for him as there are no services available for him, there is a waiting list and noone available to give those services.  His blood work prior to this vaccine was normal, and now a lot of his levels are  high and abnormal.  He also has very very dark circles around his eyes.  He is not gaining weight, he is very very picky and does not tolerate textures of food, he does not feed himself, they have been potty training him every day for years, and he is still not potty trained.  He was eating prior to the vaccine.  He was admitted to the hospital and was supposed to have an MRI but the schedule did not accommodate that.  He was crying in pain for his ears, and the jerking movements is why he was admitted, and the MRI showed that he has chronic inflammation and internal damage to the ear canal.  He had no ear issues prior to that vaccine and would respond before.
Age: 1.17
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Eye disorder, Eye movement disorder, Feeding disorder, Food intolerance, Immediate post-injection reaction
Clinical narrative: He got his vaccine.  He instantly after the MMR he was talking and he literally went mute and he has not talked since. His eye was turning to the side, became a dead eye, started twitching and jerking, always crying like he was in pain, always banging his ears, and they could not tell her what the problem was.  He became very sensitive to foods, would not eat certain foods, doing sudden movements.  A few months later he started spinning, standing in the floor and spinning.  His head and hands were jerking immediately after that vaccine.  The doctor sent mother for further testing, and informed her that nothing was wrong with his eye and that he was having temporary things.  That doctor left that office, and was then and now seeing a different pediatricians.  He started having high fever, and rashes and was told that he was fine.  He had 3 sets of 5 different shots 9/11/19 at 2 months, the Rotovirus, polio, Hep B, Hip, PCV and Dtab.  Then 11/12/19 he had the same vaccines, then on 1/14/20 he had the same 5 vaccines again.  They did not tell her at that time that they were multiple shots at one until she requested a copy of his records.  She would not have allowed it as it was too many at that time.  Each time after those reactions he was reacting different ways, but the worst one was the MMR.    He was diagnosed with autism at 21 months after testing from reaction to the MMR vaccine.  He was evaluated by the developmental pediatrician and had testing that showed that he had very high levels of aluminum in his system.  He was developing normally, talking, pointing, interacting, social, no eye problems, no twitching prior to this vaccine.  He is not able to talk at all, and prior he was saying 30 words.  He is still having the abnormal jerking and twitching movements, his eyes are going in and out.  The MRI showed that he had internal damage to his ear canal.  He still has high aluminum levels, and has not had any vaccines since then.  They have been waiting for therapy for him as there are no services available for him, there is a waiting list and noone available to give those services.  His blood work prior to this vaccine was normal, and now a lot of his levels are  high and abnormal.  He also has very very dark circles around his eyes.  He is not gaining weight, he is very very picky and does not tolerate textures of food, he does not feed himself, they have been potty training him every day for years, and he is still not potty trained.  He was eating prior to the vaccine.  He was admitted to the hospital and was supposed to have an MRI but the schedule did not accommodate that.  He was crying in pain for his ears, and the jerking movements is why he was admitted, and the MRI showed that he has chronic inflammation and internal damage to the ear canal.  He had no ear issues prior to that vaccine and would respond before.
Age: 1.17
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Magnetic resonance imaging head abnormal, Muscle twitching, Pyrexia, Rash, Unresponsive to stimuli
Clinical narrative: He got his vaccine.  He instantly after the MMR he was talking and he literally went mute and he has not talked since. His eye was turning to the side, became a dead eye, started twitching and jerking, always crying like he was in pain, always banging his ears, and they could not tell her what the problem was.  He became very sensitive to foods, would not eat certain foods, doing sudden movements.  A few months later he started spinning, standing in the floor and spinning.  His head and hands were jerking immediately after that vaccine.  The doctor sent mother for further testing, and informed her that nothing was wrong with his eye and that he was having temporary things.  That doctor left that office, and was then and now seeing a different pediatricians.  He started having high fever, and rashes and was told that he was fine.  He had 3 sets of 5 different shots 9/11/19 at 2 months, the Rotovirus, polio, Hep B, Hip, PCV and Dtab.  Then 11/12/19 he had the same vaccines, then on 1/14/20 he had the same 5 vaccines again.  They did not tell her at that time that they were multiple shots at one until she requested a copy of his records.  She would not have allowed it as it was too many at that time.  Each time after those reactions he was reacting different ways, but the worst one was the MMR.    He was diagnosed with autism at 21 months after testing from reaction to the MMR vaccine.  He was evaluated by the developmental pediatrician and had testing that showed that he had very high levels of aluminum in his system.  He was developing normally, talking, pointing, interacting, social, no eye problems, no twitching prior to this vaccine.  He is not able to talk at all, and prior he was saying 30 words.  He is still having the abnormal jerking and twitching movements, his eyes are going in and out.  The MRI showed that he had internal damage to his ear canal.  He still has high aluminum levels, and has not had any vaccines since then.  They have been waiting for therapy for him as there are no services available for him, there is a waiting list and noone available to give those services.  His blood work prior to this vaccine was normal, and now a lot of his levels are  high and abnormal.  He also has very very dark circles around his eyes.  He is not gaining weight, he is very very picky and does not tolerate textures of food, he does not feed himself, they have been potty training him every day for years, and he is still not potty trained.  He was eating prior to the vaccine.  He was admitted to the hospital and was supposed to have an MRI but the schedule did not accommodate that.  He was crying in pain for his ears, and the jerking movements is why he was admitted, and the MRI showed that he has chronic inflammation and internal damage to the ear canal.  He had no ear issues prior to that vaccine and would respond before.
Age: 1.17
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Weight gain poor
Clinical narrative: He got his vaccine.  He instantly after the MMR he was talking and he literally went mute and he has not talked since. His eye was turning to the side, became a dead eye, started twitching and jerking, always crying like he was in pain, always banging his ears, and they could not tell her what the problem was.  He became very sensitive to foods, would not eat certain foods, doing sudden movements.  A few months later he started spinning, standing in the floor and spinning.  His head and hands were jerking immediately after that vaccine.  The doctor sent mother for further testing, and informed her that nothing was wrong with his eye and that he was having temporary things.  That doctor left that office, and was then and now seeing a different pediatricians.  He started having high fever, and rashes and was told that he was fine.  He had 3 sets of 5 different shots 9/11/19 at 2 months, the Rotovirus, polio, Hep B, Hip, PCV and Dtab.  Then 11/12/19 he had the same vaccines, then on 1/14/20 he had the same 5 vaccines again.  They did not tell her at that time that they were multiple shots at one until she requested a copy of his records.  She would not have allowed it as it was too many at that time.  Each time after those reactions he was reacting different ways, but the worst one was the MMR.    He was diagnosed with autism at 21 months after testing from reaction to the MMR vaccine.  He was evaluated by the developmental pediatrician and had testing that showed that he had very high levels of aluminum in his system.  He was developing normally, talking, pointing, interacting, social, no eye problems, no twitching prior to this vaccine.  He is not able to talk at all, and prior he was saying 30 words.  He is still having the abnormal jerking and twitching movements, his eyes are going in and out.  The MRI showed that he had internal damage to his ear canal.  He still has high aluminum levels, and has not had any vaccines since then.  They have been waiting for therapy for him as there are no services available for him, there is a waiting list and noone available to give those services.  His blood work prior to this vaccine was normal, and now a lot of his levels are  high and abnormal.  He also has very very dark circles around his eyes.  He is not gaining weight, he is very very picky and does not tolerate textures of food, he does not feed himself, they have been potty training him every day for years, and he is still not potty trained.  He was eating prior to the vaccine.  He was admitted to the hospital and was supposed to have an MRI but the schedule did not accommodate that.  He was crying in pain for his ears, and the jerking movements is why he was admitted, and the MRI showed that he has chronic inflammation and internal damage to the ear canal.  He had no ear issues prior to that vaccine and would respond before.
Age: 84.0
Sex: F
Vaccine: FLU4, PNC20, TDAP
Symptoms: Syncope
Clinical narrative: patient fainted the day following receiving the vaccinations. patient is okay
Age: 26.0
Sex: F
Vaccine: COVID19-2
Symptoms: Axillary pain, Pain in extremity
Clinical narrative: Left Arm Pain & Left Underarm Pain - started the day after I was given the Vaccine and still hasn?t stopped
Age: 17.0
Sex: U
Vaccine: UNK
Symptoms: Blood glucose, Dizziness, Electrocardiogram, Visual impairment
Clinical narrative: within one hour lightheaded, dizzy and vision changes      resolved in 10 minutes
Age: 72.0
Sex: M
Vaccine: FLU4
Symptoms: Gait disturbance, Magnetic resonance imaging, Swelling, Tendon pain, Walking aid user
Clinical narrative: Patient reported severe pain and swelling in their achilles within 4 hours of the vaccine. The patient stated they had to have an x-ray and MRI to address their problem. The patient stated they were on crutches for 10 days and could barely walk.
Age: 72.0
Sex: M
Vaccine: FLU4
Symptoms: X-ray
Clinical narrative: Patient reported severe pain and swelling in their achilles within 4 hours of the vaccine. The patient stated they had to have an x-ray and MRI to address their problem. The patient stated they were on crutches for 10 days and could barely walk.
Age: 80.0
Sex: F
Vaccine: DTAP
Symptoms: Abdominal pain, Vomiting
Clinical narrative: Vomiting  abdominal pain
Age: 74.0
Sex: M
Vaccine: FLU4
Symptoms: Peripheral swelling
Clinical narrative: Patient reported arm swelling the day after receiving the high dose fluzone injection.
Age: 54.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Hypertension, Intraocular pressure increased
Clinical narrative: Significantly raised  IOP (intraocular eye pressure).
Age: 77.0
Sex: F
Vaccine: FLU4, RSV
Symptoms: Erythema, Papule, Rash, Rash pruritic
Clinical narrative: pruritic rash on left forearm and left side trunk: erythematous papules started the day after vaccine and worsening locally Treatment with triamcinolone topically; loratadine 10mg QD and famotidine 20mg BID